MedPath

Evaluation of the Sensitivity and Specificity of three Point of Care Tests (POCT) for Determination of SARS-Cov-2 (COVID-19), including a User Performance Evaluation for two devices

Conditions
SARS-CoV-2 Infection Status
Registration Number
DRKS00025374
Lead Sponsor
MED TRUST Handelsges.m.b.H.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Age: 18 – 80 years
2. Subjects who agree to the utilization of their samples in terms of sample processing, storage, analysis, documentation, optional shipment as required by the applied SARS-CoV-2 antigen tests and publication of study results.

Exclusion Criteria

1. Lack of compliance or other justifications that precludes satisfactory participation in the study in the opinion of the Investigator.
2. Inability to understand the nature and the extent of the study and the procedures required.
3. Participation without legal capacity.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Test A, Test B, and Test C fulfill the Regulatory Requirements for Sensitivity, Specificity and Home use. Rapid Test results are referenced by RT-PCR (EURORealTime SARS-CoV-2 PCR Test Kit ).
Secondary Outcome Measures
NameTimeMethod
ser performance evaluation for tests A and B.
© Copyright 2025. All Rights Reserved by MedPath